FR3111542B1 - Composition pharmaceutique ou diététique contenant de l’extrait aqueux de la lavande et utilisable comme antibactérien et antifungique - Google Patents
Composition pharmaceutique ou diététique contenant de l’extrait aqueux de la lavande et utilisable comme antibactérien et antifungique Download PDFInfo
- Publication number
- FR3111542B1 FR3111542B1 FR2006476A FR2006476A FR3111542B1 FR 3111542 B1 FR3111542 B1 FR 3111542B1 FR 2006476 A FR2006476 A FR 2006476A FR 2006476 A FR2006476 A FR 2006476A FR 3111542 B1 FR3111542 B1 FR 3111542B1
- Authority
- FR
- France
- Prior art keywords
- aqueous extract
- lavender
- antifungal
- antibacterial
- usable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Composition pharmaceutique ou diététique contenant de l’extrait aqueux de lavande et utilisable comme antibactérien et antifongique. Selon l'invention, cette composition peut en outre comprendre un extrait aqueux d'au moins une deuxième plante parmi les plantes suivantes : Punica granatum L, Rosmarinus officinalis L, Salvia officinalis L, Origanum compactum, Origanum majorana.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR2006476A FR3111542B1 (fr) | 2020-06-21 | 2020-06-21 | Composition pharmaceutique ou diététique contenant de l’extrait aqueux de la lavande et utilisable comme antibactérien et antifungique |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR2006476A FR3111542B1 (fr) | 2020-06-21 | 2020-06-21 | Composition pharmaceutique ou diététique contenant de l’extrait aqueux de la lavande et utilisable comme antibactérien et antifungique |
FR2006476 | 2020-06-21 |
Publications (2)
Publication Number | Publication Date |
---|---|
FR3111542A1 FR3111542A1 (fr) | 2021-12-24 |
FR3111542B1 true FR3111542B1 (fr) | 2023-01-13 |
Family
ID=72644394
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR2006476A Active FR3111542B1 (fr) | 2020-06-21 | 2020-06-21 | Composition pharmaceutique ou diététique contenant de l’extrait aqueux de la lavande et utilisable comme antibactérien et antifungique |
Country Status (1)
Country | Link |
---|---|
FR (1) | FR3111542B1 (fr) |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2950808B1 (fr) * | 2009-10-02 | 2011-11-18 | Titis Business Corp Tbc | Composition pharmaceutique ou dietetique pour inhiber la contraction des muscles lisses |
EP3035946A1 (fr) * | 2013-08-20 | 2016-06-29 | SWM Luxembourg s.a.r.l. | Produit comprenant une plante pour un usage médicinal, cosmétique, de coloration ou dermatologique |
FR3072567A1 (fr) * | 2017-10-19 | 2019-04-26 | Bruno Eto | Composition pharmaceutique ou dietetique contenant de l’extrait d’origanum majorana et utilisable pour reguler le cycle enterosystemique intestinal de l’eau. |
FR3077732B1 (fr) * | 2018-02-15 | 2020-11-13 | Robertet | Procede d’obtention d’un extrait enrichi en acide rosmarinique a partir de matiere vegetale fraiche |
CN110373395B (zh) * | 2019-06-05 | 2021-03-26 | 中国农业科学院北京畜牧兽医研究所 | 提高漆酶对真菌毒素降解率的薰衣草介体及其应用 |
-
2020
- 2020-06-21 FR FR2006476A patent/FR3111542B1/fr active Active
Also Published As
Publication number | Publication date |
---|---|
FR3111542A1 (fr) | 2021-12-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Hussein et al. | Evaluation of cytotoxicity, biochemical profile and yield components of groundnut plants treated with nano-selenium | |
Becker et al. | Bioactivity guided isolation of antimicrobial compounds from Lythrum salicaria | |
Özçelik et al. | Antibacterial, antifungal, and antiviral activities of the lipophylic extracts of Pistacia vera | |
BR0009430A (pt) | Cepa do bacilo pumilus para controle de doenças de plantas | |
Khan et al. | In vitro antibacterial, antifungal and GC-MS analysis of seeds of Mustard Brown | |
Egamberdieva et al. | Medicinal plants and PGPR: a new frontier for phytochemicals | |
Moradi et al. | Quorum-quenching activity of some Iranian medicinal plants | |
YILMAZ et al. | Comparison of the antimicrobial activity of some Scutellaria orientalis L. taxa growing in Turkey | |
FR3111542B1 (fr) | Composition pharmaceutique ou diététique contenant de l’extrait aqueux de la lavande et utilisable comme antibactérien et antifungique | |
MA51927A1 (fr) | Composition pharmaceutique ou diététique contenant de l’extrait aqueux de la lavande et utilisable comme antibactérien et antifungique | |
Manoorkar et al. | Antifungal activity of leaf and latex extracts of Calotropis procera (Ait.) against dominant seed-borne storage fungi of some oil seeds | |
Lukošiūtė et al. | The effect of Lamiaceae plants essential oils on fungal plant pathogens in vitro | |
Shanayda et al. | Antimicrobial activity of essential oils of plants belonging to Lamiaceae Juss. family | |
Behravan et al. | Antimycotic activity of the essential oil of Satureja mutica Fisch & CA Mey from Iran | |
Awaad et al. | Phytochemical analysis and antimicrobial activity of medicinal plants against pathogenic microorganisms | |
Najjaa et al. | Antimicrobial activities of protenic extracts of Allium roseum L., a wild edible species in North Africa | |
Kačániová et al. | In vitro antimicrobial activity of four Slovak medicinal plants against different strains of bacteria | |
Al-Judaibi et al. | Antifungal effect of ethanol plant extract on Candida sp | |
EL-HABBAA et al. | In vitro evaluation of some fungicides, commercial biocontrol formulations and natural plant extracts on peanut root-rot pathogens | |
Musheer et al. | Potential of Plant Growth-Promoting Microbes in Disease Reduction by Influencing the Antioxidant Enzymes of Medicinal and Spice Plants | |
BR0203466A (pt) | Extrato de um isolado de bactéria da pele, método para tratamento, isolado bacteriano, métodos de identificar metabólitos bacterianos, extratos, frações ou compostos biologicamente, extrato, fração ou composto biologicamente ativo, composição farmacêutica, e, métodos de inibir o crescimento de organismos patogênicos em um indivìduo, de células tumorais em um indivìduo, e de um vìrus em um indivìduo | |
Ćirić et al. | Recent Advances in Science of Quorum Sensing: An Overview of Natural Product Inhibitors | |
Kannan | Chapter-8 biological management of plant diseases | |
Castro et al. | Antimicrobial activity of biogenic hop-based silver nanoparticles for application in sugar and alcohol industries | |
Rahanandeh et al. | The inhibitory effect of five plant extracts on the pathogen of mulberry dieback disease (Sclorotinia sclerotiorum) in laboratory conditions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PLFP | Fee payment |
Year of fee payment: 3 |
|
PLSC | Publication of the preliminary search report |
Effective date: 20211224 |
|
PLFP | Fee payment |
Year of fee payment: 4 |